Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

DSpace Repository

Show simple item record

dc.contributor.author Kopp, Hans-Georg
dc.date.accessioned 2020-05-28T12:51:01Z
dc.date.available 2020-05-28T12:51:01Z
dc.date.issued 2019
dc.identifier.issn 1432-1335
dc.identifier.uri http://hdl.handle.net/10900/101056
dc.language.iso en en
dc.publisher Springer de_DE
dc.relation.uri http://dx.doi.org/10.1007/s00432-018-2752-z
dc.subject.ddc 610 de_DE
dc.title Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group de_DE
dc.type Artikel de_DE
utue.quellen.id 20190926111821_02446
utue.publikation.seiten 717-723 de_DE
utue.personen.roh Fenner, Martin
utue.personen.roh Oing, Christoph
utue.personen.roh Dieing, Annette
utue.personen.roh Gauler, Thomas
utue.personen.roh Oechsle, Karin
utue.personen.roh Lorch, Anja
utue.personen.roh Hentrich, Marcus
utue.personen.roh Kopp, Hans-Georg
utue.personen.roh Bokemeyer, Carsten
utue.personen.roh Honecker, Friedemann
dcterms.isPartOf.ZSTitelID Journal of Cancer Research and Clinical Oncology de_DE
dcterms.isPartOf.ZS-Issue 3 de_DE
dcterms.isPartOf.ZS-Volume 145 de_DE
utue.fakultaet 04 Medizinische Fakultät


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record